Supported
Broad functional range and strong distance performance.
Short-term Odyssey-specific cohorts support useful vision across distances; superior near vision is not established.
Review pp. 05–07 · references 4–6Evidence Review · 04
TECNIS Odyssey
Has the Full-Range Trade-off Changed?
TECNIS Odyssey extends the full-range diffractive concept with a different balance across distance, intermediate, near vision, refractive tolerance and quality of vision. Current evidence supports broad functional vision and strong distance performance. Direct comparisons show endpoint-specific differences. Higher measured bench straylight does not automatically mean greater patient-perceived glare.
Read opens the full PDF in a new tab.
The evidence review in one minute
Four key evidence points
Emerging
Refractive-tolerance and selected mesopic signals.
Tolerance depends on axis and amount. It is not permission to accept residual refractive error.
Review pp. 04–05 · references 3, 10Comparator context
PanOptix and PanOptix Pro are separate generations.
Synergy is predecessor context, not Odyssey-specific evidence. Comparative findings remain endpoint-specific.
Review pp. 04, 08–09 · references 3, 7–8Not yet established
Overall quality-of-vision superiority or greater clinical glare.
Higher in-vitro straylight does not demonstrate greater patient-perceived glare. No significant difference does not prove equivalence.
Review pp. 09–12 · references 7–9The central question
Does Odyssey improve the traditional full-range trade-off—or redistribute it?
OIE interpretation
Odyssey appears to redistribute the full-range trade-off, with promising gains in selected domains.
The definitive full evidence review
Follow the evidence.
Complete evidence, methods and references are in the PDF.
Read the PDF on this page
If your browser does not display the reader, open the PDF directly.
Publication transparency
These declarations concern OIE and its author. They do not describe the funding or financial relationships of the studies reviewed.
Evidence appraised through 20 September 2026. Version 1.0. Later findings may change interpretation.